Abstract:Injuries of mature central nervous system (CNS) axons result in loss of vital functions due to the failure of CNS axons to regenerate. AKT, a family of serine/threonine-specific protein kinases, induces CNS axon regeneration through activation of the mTOR signaling. However, mTOR participates in two distinct complexes, mTOR complex 1 (mTORC1) and complex 2 (mTORC2). How these two complexes interact with regard to axon regeneration is unknown. To exploit the significant advantages of specific tropism of adeno-associated virus serotype 2 (AAV2) for retinal ganglion cells (RGC) after intravitreal injection, we generated a series of triple tyrosine-optimized AAV2 (NexGen AAV2) vectors carrying different AKT variants and mutants. We first confirmed that the NexGen viral vectors showed significant more infection efficiency compared to vectors based on wild-type AAV2 capsids. More than 90% RGC cells in whole-mount retina was transduced, based on triple immunofluorescent staining of transgene, RGC marker, and active form of AKT. Then, the optic nerve was crushed as an in vivo axon regeneration model in mice 2 weeks post-intravitreal injection of AAV vectors. It was observed that the predominant AKT isoform in brain and retina, AKT3, induces much better axon regeneration than AKT1 and AKT2. Next, we evaluated the roles of mTORC1 and mTORC2 in AKT3-induced CNS axon regeneration. NexGen AAV2 vectors carrying AKT3 and Cre were injection into eyes of either mTOR floxed mice, RAPTOR floxed mice, or RICTOR floxed mice. RAPTOR is unique to mTORC1, whose deletion totally blocks mTORC1 activity; whilst RICTOR is a rapamycin-insensitive component essential for mTORC2 activity. As expected, deletion of mTOR or RAPTOR significantly inhibited AKT3-induced axon regeneration. Interestingly, AKT3 and RICTOR KO produced even more extensive and fine axon regeneration than AKT3 alone, suggesting that mTORC2 is inhibitory for AKT3-induced CNS axon regeneration. Furthermore, NexGen AAV2-mediated delivery of dominant negative mutant of ribosomal protein S6 kinase (S6K1) or constitutively active mutant of factor 4E-binding protein (4E-BP1), two best-characterized substrates of mTORC1, also inhibited AKT3-induced axon regeneration, further corroborating our conclusions. In addition, since S472 of AKT3 is phosphorylated by mTORC2, we generated NexGen AAV2 vectors carrying an AKT3-S472A mutant gene. Other mutant genes, such as AKT3 kinase dead mutant (K177M) and T305A mutant, were used as appropriate controls. Our results indicated that neither of the control mutants induced axon regeneration. However, the AKT3-S472A mutant produced a significant increase in axon regeneration compared to wild-type AKT3. Taken together, our study revealed an AKT-based neuron-intrinsic balancing mechanism involving mTORC1 and mTORC2, which coordinates positive and negative cues to regulate adult CNS axon regeneration, respectively. Our results should provide promising therapeutic targets for CNS injuries. Taken together, our study revealed an AKT-based neuron-intrinsic balancing mechanism involving mTORC1 and mTORC2, which coordinates positive and negative cues to regulate adult CNS axon regeneration, respectively. Our results should provide promising therapeutic targets for CNS injuries.

Effects of constitutively active K-Ras on axon regeneration after optic nerve injury

271. Strategies Based on NexGen AAV2 to Improve AKT3-Induced CNS Axon Regeneration in Vivo

Ca2+/Calmodulin-Dependent Protein Kinase II Enhances Retinal Ganglion Cell Survival But Suppresses Axon Regeneration after Optic Nerve Injury

Rac1 selective activation improves retina ganglion cell survival and regeneration

Neuroprotection and axon regeneration in glaucoma models by gene therapy using modified tyrosine kinase receptors

AAV-mediated Transfer of RhoA Shrna and CNTF Promotes Retinal Ganglion Cell Survival and Axon Regeneration

Phosphorylated S6K1 and 4E-BP1 play different roles in constitutively active Rheb-mediated retinal ganglion cell survival and axon regeneration after optic nerve injury

Casein kinase-II inhibition promotes retinal ganglion cell survival and axonal regeneration.

Long-Term Rescue Of Rat Retinal Ganglion Cells And Visual Function By Aav-Mediated Bdnf Expression After Acute Elevation Of Intraocular Pressure

Promoting Axon Regeneration in the Adult CNS by Modulation of the PTEN/mTOR Pathway

PI3K/akt, JAK/STAT and MEK/ERK pathway inhibition protects retinal ganglion cells via different mechanisms after optic nerve injury

Rescue of retinal ganglion cells in optic nerve injury using cell-selective AAV mediated delivery of SIRT1

Protective Effects of Intravitreal Injection of the Rho-Kinase Inhibitor Y-27632 in a Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy (Raion)

Exploring Optic Nerve Axon Regeneration.

Exploring Optic Nerve Axon Regeneration

Optic Nerve Crush in Mice to Study Retinal Ganglion Cell Survival and Regeneration.

In vivo cellular imaging of various stress/response pathways using AAV following axonal injury in mice

AAV-mediated Expression of CNTF Promotes Long-Term Survival and Regeneration of Adult Rat Retinal Ganglion Cells

RSK1 promotes mammalian axon regeneration by inducing the synthesis of regeneration-related proteins

Dual Specific Phosphatase 14 Deletion Rescues Retinal Ganglion Cells and Optic Nerve Axons after Experimental Anterior Ischemic Optic Neuropathy

BDNF Improves Axon Transportation and Rescues Visual Function in a Rodent Model of Acute Elevation of Intraocular Pressure